Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal versus intrauterine misoprostol for reducing blood loss during caesarean section
PACTR202502678979460Not yet recruiting
- Sponsor
- Dr Chukwuka Chude Eze
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Dr Chukwuka Chude Eze. Primary endpoints: Mean intra-operative blood loss and Change in haematocrit at 48 hours postoperatively. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202502678979460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502678979460.